{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.52",
    "chg": -0.25,
    "chgp": "-0.9%",
    "dir": -1,
    "prev_price": "27.77",
    "mcapval": "46.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE829A01014",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "15.47 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 141,
    "sid": "386748",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "01-Apr-2026",
      "details": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2026",
      "details": "Closure of Trading Window period for the quarter and financial year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2026",
      "details": "Submission of Publication of Un-audited Financial Results for the quarter and nine months ended on 31st December 2025 in the newspaper pursuant to Regulation 47 of SEBI( Listing Obligation and Disclosure Requirement ) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News